MEDICAL CENTER ENTERPRISE
1. Target Overview & Investment Thesis
MEDICAL CENTER ENTERPRISE is a 99-bed suburban community hospital in COFFEE, AL with $59.1M in net patient revenue and a 1.6% operating margin. The hospital serves a payer mix of 26.1% Medicare, 23.2% Medicaid, and 50.7% commercial.
Thesis: Turnaround. Our ML models identify $4.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.6% to 8.9% (+736bps).
| Net Revenue HCRIS | $59.1M |
| Current EBITDA COMPUTED | $918K |
| Operating Margin COMPUTED | 1.6% |
| Occupancy HCRIS | 38.1% |
| Revenue / Bed COMPUTED | $597K |
| Net-to-Gross HCRIS | 6.5% |
| Distress Probability ML | 53.9% |
2. Market Context & Competitive Position
AL has 115 Medicare-certified hospitals with a median operating margin of -8.5%. The target's margin of 1.6% places it above the state median. Among 29 size-comparable peers (50-198 beds), the median margin is -4.3%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (50-198), prioritizing same-state peers. 29 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| MEDICAL CENTER ENTERPRISE (Target) | AL | 99 | $59.1M | 1.6% |
| CRESTWOOD MEDICAL CENTER | AL | 164 | $258.9M | 14.6% |
| THOMAS HOSPITAL | AL | 164 | $244.7M | 6.2% |
| FLOWERS HOSPITAL | AL | 193 | $235.5M | 14.2% |
| SPRINGHILL MEMORIAL HOSPITAL | AL | 179 | $216.2M | -3.8% |
| MARSHALL MEDICAL CENTERS SOUTH | AL | 178 | $186.9M | -6.3% |
| SOUTH BALDWIN REGIONAL MEDICAL | AL | 112 | $168.2M | 46.4% |
| CULLMAN REGIONAL | AL | 137 | $167.1M | -4.9% |
| HELEN KELLER HOSPITAL | AL | 178 | $92.0M | -28.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.2M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.2M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.2M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $719K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $38K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $918K |
| + RCM Uplift | +$4.4M |
| Pro Forma EBITDA | $5.3M |
| Current Margin | 1.6% |
| Pro Forma Margin | 8.9% |
| WC Released (1x) | $2.3M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $1.4M | $49.6M | 35.12x | 103.8% |
| Base (11x exit) | 10.0x | 11.0x | $1.4M | $55.0M | 38.96x | 108.0% |
| Bull Case | 9.0x | 11.0x | $1.3M | $69.8M | 54.95x | 122.8% |
| Bull (12x exit) | 9.0x | 12.0x | $1.3M | $76.5M | 60.24x | 127.0% |
| Bear Case | 11.0x | 10.0x | $1.6M | $27.4M | 17.62x | 77.5% |
| Bear (11x exit) | 11.0x | 11.0x | $1.6M | $30.6M | 19.70x | 81.5% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Elevated Medicaid exposure (23.2%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| High | Elevated distress probability | Model estimates 53.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 29 hospitals with 50-198 beds
- Same-state prioritization (n=30)
- Comp margins: P25=-16.0% / P50=-4.3% / P75=12.1%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.